RGEN Competitors
Repligen Corporation
$184.17
+$5.97(+3.35%)
47
Overall
40
Value
50
Tech
52
Quality
Market Cap
$8.72B
Volume
313.85K
52W Range
$100.99 - $198.87
Target Price
$193.15
RGEN competitors: NVAX, BMRN, NBIX, GE, CRL. Repligen Corporation is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
RGEN Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| NVAX Novavax, Inc. | $12.64 | $2.08B | $-0.48 | - | 60 |
| BMRN BioMarin Pharmaceutical Inc. | $55.14 | $10.67B | $4.10 | - | 48 |
| NBIX Neurocrine Biosciences, Inc. | $135.91 | $13.82B | $7.26 | - | 53 |
| GE GE Aerospace | $307.02 | $319.19B | $7.91 | 0.42% | 37 |
| CRL Charles River Laboratories International, Inc. | $302.00 | $14.42B | $11.36 | - | 60 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RGEN | $184.17 | +3.4% | 313.85K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |